Expression of Growth Hormone Receptor in human prostatic carcinoma and hyperplasia

International Journal of Oncology

Volumn 14, Issue 5, 1999, Pages 911-916

  Kölle, Sabine ^a   Sinowatz, Fred ^a   Boie, Gudrun ^a   Temmim Baker, Labiba ^b   Lincoln, David ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Growth hormone receptor; Human prostatic tumor; Immunohistochemistry; RT PCR

Indexed keywords

GROWTH HORMONE RECEPTOR; MESSENGER RNA;

ADULT; ARTICLE; BIOSYNTHESIS; CANCER STAGING; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; PROSTATE; PROSTATE HYPERTROPHY; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, SOMATOTROPIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033125537     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.5.911     Document Type: Article

References (36)

1. Oesterling JE: Benign prostatic hyperplasia: its natural history, epidemiologic characteristics, and surgical treatment. Arch Fam Med 1: 257-266, 1992.
2. Parker SL, Tong T, Bolden S and Wingo PA: Cancer statistics. 1996. Cancer J Clin 65: 5-27, 1996.
3. Gittes RF: Carcinoma of the prostate. N Engl J Med 324: 236-245, 1991.
4. Stearns ME and McGarvey T: Prostate cancer: therapeutic, diagnostic, and basic studies. Lab Invest 67: 540-552, 1992.
5. Schally AV, Comaru-Schally AM and Gonzales-Barcen D: Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer. Biomed Pharmacother 46: 464-471, 1990.
6. Syms AJ, Harper ME and Griffiths K: The effect of prolactin on human BPH epithelial cell proliferation. Prostate 6: 145-153, 1985.
7. Reubi JC, Waser B, Schaer JC and Markwalder R: Somatostatin receptors in human prostate and prostate cancer. J Clin Endocrinol Metab 80: 2806-2814, 1995.
8. Reiter E, Kecha O, Hennuy B, Lardinois S, Klug M, Bruyninx M, Closset J and Hennen G: Growth hormone directly affects the function of the different lobes of the rat prostate. Endocrinology 136: 3338-3345, 1995.
9. McKeehan WL, Adams PS and Fast P: Different hormonal requirements for androgen-independent growth of normal and tumor epithelial cells from rat prostate. In Vitro Cell Dev Biol 23: 147-152, 1985.
10. Eaton CL, Davies P and Philipps MEA: Growth factor involvement and oncogene expression in prostatic tumours. J Steroid Biochem 30: 341-345, 1988.
11. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP and Kreutzer DL: Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J Urol 157: 2329-2333, 1997.
12. Jackson MW, Bentel JM and Teilley WD: Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. J Urol 157: 2323-2428, 1997.
13. Djonov V, Ball RK, Graf S, Mottaz AE, Arnold AM, Flanders K, Studer UE and Merz VW: Transforming growth factor-beta 3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinoma. Prostate 31: 103-109, 1997.
14. Guo Y, Jacobs SC and Kyprianou N: Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer. Int J Cancer 71: 573-579, 1997.
15. Angelloz-Nicoud P and Binoux M: Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology 136: 5485-5492, 1995.
16. Chan J, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH and Pollak M: Plasma insulin-like growth factor I and prostate cancer risk: a prospective study. Science 279: 563-566, 1998.
17. Manni A, Boucher AE, Demers LM, Harvey HA, Lipton A, Simmonds MA and Bartholomew M: Somatostatin analogues in the treatment of breast and prostate cancer. J Steroid Biochem Mol Biol 37: 1083-1087, 1990.
18. Jungwirth A, Schally AV, Pinski J, Halmos G, Groot K, Armatis P and Vadillo-Buenfil M: Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone. Br J Cancer 75: 1585-1592, 1997.
19. Mostofi FK, Sesterhenn IA and Sobin LH: Histological typing of prostate tumours. International histological classification of tumours. No. 22. World Health Organisation, Geneva, 1980.
20. Sharara FI and Nieman LK: Identification and cellular localization of growth hormone receptor gene expression in the human ovary. J Clin Endocrinol Metab 79: 670-672, 1994.
21. Scott P, Kessler MA and Schuler LA: Molecular cloning of the bovine prolactin receptor and distribution of prolactin and growth hormone receptor transcripts in fetal and utero-placental tissues. Mol Cell Endocrinol 89: 47-58, 1992.
22. Barnard R, Bundesen PG, Rylatt DB and Waters MJ: Monoclonal antibodies to the rabbit liver growth hormone receptor: production and characterization. Endocrinology 115: 1803-1813, 1984.
23. Barnard R, Bundesen PG, Rylatt DB and Waters MJ: Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor. Biochem J 231: 459-468, 1985.
24. Lincoln DT, Sinowatz F, Temmim-Baker L, Baker HI, Kölle S and Waters MJ: Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells. Histochem Cell Biol 109: 141-159, 1998.
25. Lobie PE, Breipohl W, Aragón JG and Waters MJ: Cellular localization of the growth hormone receptor/binding protein in the male and female reproductive systems. Endocrinology 126: 2214-2221, 1990.
26. Kölle S, Sinowatz F, Boie G, Lincoln D and Waters MJ: Differential expression of the growth hormone receptor and its transcript in bovine uterus and placenta. Mol Cell Endocrinol 131: 127-136, 1997.
27. Kölle S, Sinowatz F, Boie G, Lincoln D, Palma G, Stojkovic M and Wolf E: Topography of growth hormone receptor expression in the bovine embryo. Histochem Cell Biol 109: 417-419, 1998.
28. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
29. Sibley PEC, Harper ME, Peeling WB and Griffiths K: Growth hormone and prostatic tumours: localization using a monoclonal human growth hormone antibody. J Endocrinol 103: 311-315, 1984.
30. Sinowatz F, Breipohl W, Waters MJ, Lincoln D, Lobie PE and Amselgruber W: Growth hormone receptor expression in the Dunning R3327 prostatic carcinoma of the rat. Prostate 19: 273-278, 1991.
31. Siegel RA, Tolcsvai L and Rudin M: Partial inhibition of the growth of transplanted Dunning rat prostate tumors with the long-acting somatostatin analogue sandostatin (SMS 201-995). Cancer Res 48: 4651-4655, 1988.
32. Zalatnai A, Paz-Bouza JI, Redding TW and Schally AV: Histologic changes in the rat prostate cancer model after treatment with somatostatin analogues and D-Trp-6-LH. Prostate 12: 85-98, 1988.
33. Kölle S, Sinowatz F, Boie G and Lincoln D: Developmental changes in the expression of the growth hormone receptor messenger ribonucleic acid and protein in the bovine ovary. Biol Reprod 59: 836-842, 1998.
34. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzell J, Barnard R, Waters MJ and Wood WI: Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330: 537-541, 1987.
35. Lesniak MA and Roth J: Regulation of receptor concentration by homologous hormone. Effect of human GH on its receptor in IM-9 lymphocytes. J Biol Chem 251: 3720-3729, 1976.
36. Reiter E, Bonnet P, Sente B, Domborwiez D, De Levai J, Closset J and Hennen G: Growth hormone and prolactin stimulate androgen receptor, insulin-like growth factor-I (IGF-I) and IGF-I receptor levels in the prostate of immature rats. Mol Cell Endocrinol 88: 77-87, 1992.